Interactive Brokers Appointed International Broker for Sinopac Securities
16.2.2023 09:00:00 EET | Business Wire | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, announced its appointment as the primary international broker for Sinopac Securities today. Institutional and retail clients of Sinopac can trade US stocks, ETFs, and Fixed Income instruments while also accessing over 90 stock markets worldwide through Interactive Brokers. This initiative between Interactive Brokers LLC and Sinopac strengthens Interactive Brokers’ footprint in the APAC region and adds Taiwan to the over 200 countries and territories worldwide where the company services clients.
“We are pleased to work with Sinopac and bring Interactive Brokers’ global trading capabilities and expertise to Taiwan,” said Milan Galik, Chief Executive Officer of Interactive Brokers. “We recognize the advantage of working with a leading broker with local experience and look forward to serving the needs of this important market and its investors.”
Taiwanese investors will benefit from Interactive Brokers’ powerful trading platforms and advanced technology and tools. Interactive Brokers offers clients the ability to trade fractional shares of eligible US and European stocks as well as ETFs and can accommodate over 100 order types, including algorithmic trading, which is currently unavailable through other brokers in Taiwan. Clients can trade select US ETFs 23½ hours a day, five days a week through Overnight Trading Hours on the IBKR Eos ATS (“IBEOS”). With Overnight Trading Hours, investors across Asia can access US Equity Markets during their trading day and respond to market-moving news at almost any time. The collaboration with Sinopac also enables clients of Interactive Brokers to trade Taiwanese stocks through Sinopac Securities.
Introducing Brokers worldwide use Interactive Brokers’ Prime Broker services to help manage their businesses with efficiency and serve their clients at a lower cost. Through Interactive Brokers, Introducing Brokers can reduce their operational, brokerage, and clearing costs while gaining electronic market access worldwide with the company’s professional, white-branded trading technology. Interactive Brokers’ turnkey solution covers trading, clearing, reporting, and billing and provides the following advantages:
- Support for global regulatory reporting
- Account funding and trading in up to 26 currencies
- Access to stocks, options, futures, currencies, bonds, and funds in over 150 markets from a single unified platform
- No ticket charges, no minimums, and no technology, software, platform, or reporting fees
- Free client relationship management tools
For additional information about Interactive Brokers’ Introducing Broker platform, please visit:
US and Countries Served by IB LLC: https://www.interactivebrokers.com/en/accounts/broker.php
Canada: https://www.interactivebrokers.ca/en/accounts/broker.php
UK: https://www.interactivebrokers.co.uk/en/accounts/broker.php
Western Europe: https://www.interactivebrokers.ie/en/accounts/broker-ie.php
Central Europe: https://www.interactivebrokers.hu/en/accounts/broker-hu.php
Hong Kong: https://www.interactivebrokers.com.hk/en/accounts/broker.php
Singapore: https://www.interactivebrokers.com.sg/en/accounts/broker.php
India: https://www.interactivebrokers.co.in/en/accounts/broker.php
Australia: https://www.interactivebrokers.com.au/en/accounts/broker.php
About Interactive Brokers Group, Inc.:
Interactive Brokers Group affiliates provide automated trade execution and custody of securities, commodities and foreign exchange around the clock on over 150 markets in numerous countries and currencies from a single unified platform to clients worldwide. We service individual investors, hedge funds, proprietary trading groups, financial advisors and introducing brokers. Our four decades of focus on technology and automation has enabled us to equip our clients with a uniquely sophisticated platform to manage their investment portfolios. We strive to provide our clients with advantageous execution prices and trading, risk and portfolio management tools, research facilities and investment products, all at low or no cost, positioning them to achieve superior returns on investments. For the fifth consecutive year, Barron’s ranked Interactive Brokers #1 with 5 out of 5 stars in its March 25, 2022, Best Online Brokers Review.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230215005686/en/
Contact information
Interactive Brokers Group, Inc
Katherine Ewert, media@ibkr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting Strengthens Digital Transformation Capabilities with Weexa30.4.2026 16:30:00 EEST | Press release
Andersen Consulting enters into a Collaboration Agreement with Weexa, a global provider of digital transformation, B2B integration, and supply chain digitalization solutions. Headquartered in France, Weexa delivers end-to-end services that help organizations streamline, secure, and scale their digital ecosystems. The firm specializes in B2B data-flow management and digitalization, enabling seamless communication between applications both within and across organizations through technologies such as EDI, APIs, and e-invoicing. Weexa also provides SAP integration and supply chain solutions spanning warehouse and transport management, alongside strategic consulting, project delivery, and third-party application maintenance. Serving organizations across the food, retail, wholesale, logistics, transportation, automotive, healthcare, and media sectors, Weexa supports global businesses in optimizing performance while meeting evolving regulatory and digital-compliance requirements. “Collaborati
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 202430.4.2026 16:22:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”). An electronic copy of the Annual Report can be accessed on SINOVAC’s investor relations website at https://www.sinovac.com/en-us/Investors and on the SEC’s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases. The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, et
Experian Announces Agent Trust to Power Trusted AI Driven Commerce30.4.2026 16:00:00 EEST | Press release
Experian today announced Experian Agent Trust™, a first-of-its-kind framework that establishes a secure, verifiable link between consumers and AI agents, bringing identity, and accountability to AI-driven transactions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430719198/en/ Experian Announces Agent Trust to Power Trusted AI Driven Commerce. As AI agents begin to search and transact autonomously, they introduce a fundamental challenge for businesses: how to trust an action when it is no longer driven by a human. Without a verified connection between humans and AI agents, autonomous commerce introduces new risks in fraud, misrepresentation, and unauthorized transactions. Experian Agent Trust addresses this challenge through a new “Know Your Agent” (KYA) framework, extending identity verification into the age of AI. The framework ensures that agent-initiated transactions are grounded in verified consumer identity. “Agen
Meet the AI-powered fan companion: TGR Haas F1 Team RaceMate powered by Infobip30.4.2026 16:00:00 EEST | Press release
Global AI-first cloud communications platform Infobip and TGR Haas F1 team are launching ‘TGR Haas F1 Team RaceMate powered by Infobip’, an AI-powered conversational fan companion on Apple Messages for Business and WhatsApp Business Platform. Always-on and always available, it delivers race intelligence for TGR Haas F1 Team: team race intelligence, grid positions, qualifying outcomes, sprint results, and full session schedules. The AI agent tracks drivers Ollie Bearman and Esteban Ocon with their individual championship standings and performance data in conversational format. The agent draws from a knowledge base covering driver biographies, team history, and circuit data, adapting to each user's knowledge level. Every interaction begins with a schedule check, ensuring fans always know what's happening right now. It proactively surfaces relevant information, suggests next actions, and maintains conversational flow to keep every interaction effortless and engaging. Delivered in short, s
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations30.4.2026 15:05:00 EEST | Press release
Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1 (NCT07332481) and ELOWEN-2 (NCT07355218), evaluating enpatoran in people living with lupus who experience active skin manifestations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430733656/en/ David Weinreich, Global Head of R&D and Chief Medical Officer “People living with lupus continue to face significant challenges in achieving disease control and are very often affected by itchy, painful and stigmatized skin manifestations,” said David Weinreich, Global Head of R&D, Merck. “With enpatoran, we aim to target the underlying drivers of lupus and redefine how to approach the disease by understanding both visible skin manifestations and systemic activity.” Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor designed to modulate pathways central to lupus-related inflammatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
